Chemotherapy wafers and implants

Chemotherapy wafers are small, thin, dissolvable discs that contain a chemotherapy medicine. The best-known type contains carmustine and is used for some fast-growing brain tumours, particularly glioblastoma, in selected patients. During brain surgery, after the neurosurgeon has removed as much of the tumour as is safely possible, several wafers may be placed on the surface of the cavity where the tumour was. Over the following weeks, the wafers slowly dissolve and release chemotherapy directly into the surrounding brain tissue, where cancer cells that could not be removed may remain. Because the medicine is released locally, it avoids some of the difficulty chemotherapy has in crossing from the bloodstream into the brain.

Wafers are used only in carefully selected situations. The decision is usually made before or during surgery, depending on the tumour type, how much can be removed, the surgical findings and other planned treatments such as radiotherapy and chemotherapy tablets. Evidence suggests a modest role for some patients, and wafers also carry specific risks, including brain swelling, seizures, wound healing problems, infection and leakage of spinal fluid. In addition, the presence of wafers can affect eligibility for some clinical trials. In India, chemotherapy wafers are not widely available, may need special import arrangements and can be costly, so many neurosurgical teams do not use them routinely. Other implanted or local delivery devices exist for some cancers, but most are specialised or experimental. Your neurosurgeon and oncologist can explain whether wafers are relevant for you.

They are part of wider treatment

Wafers are usually combined with radiotherapy and other chemotherapy, not used alone.

Not every brain tumour is suitable

Tumour type, location and the extent of surgery all influence whether wafers are considered.

Ask about trials

Because wafers may affect trial eligibility, ask about trials before surgery if relevant.

It cannot tell you whether wafers are right for your brain tumour, or what results to expect. These decisions depend on the tumour, surgery, your health and other treatments, and are made by your neurosurgical and oncology teams.

It also cannot confirm whether wafers are available at a particular hospital, or their cost. Ask your team directly.

Other local treatments

For some cancers, other implanted devices or local therapies exist, often within specialised centres or trials.

Scans can be confusing

Wafers and surgery can cause changes on scans that look like tumour. Your team will explain.

Driving and seizures

After brain surgery or seizures, driving is usually not allowed for a period. Ask your team.

Emotional impact

Brain tumours affect thinking, mood and personality. Support for patients and families is important.

Rehabilitation

Physiotherapy, occupational therapy and speech therapy may help recovery.

Clinical trials

Ask about trials early, as some treatments affect eligibility.

Second opinions

For complex brain tumour decisions, a second opinion from a specialist centre can help.

Carers need support

Caring for someone after brain surgery can be demanding. Ask about carer support.

Why getting chemotherapy into the brain is difficult

The brain is protected by a natural barrier formed by the walls of its blood vessels, which prevents many substances in the blood from entering brain tissue. This protects the brain from toxins and infections, but it also means that many chemotherapy medicines given through a vein or by mouth reach brain tumours only in small amounts. Some medicines, such as temozolomide, cross the barrier better and are commonly used for brain tumours. Wafers were developed as a way to place chemotherapy directly next to where the tumour was, bypassing the barrier altogether. However, the medicine spreads only a short distance from the wafer into surrounding tissue, which is one reason its benefit is limited to selected situations.

How the decision is usually made

The decision about wafers is often made before surgery, based on scans that suggest a fast-growing tumour and a plan to remove as much as possible. Sometimes the final decision is made during the operation, once the surgeon has seen the tumour and confirmed its likely type with a quick tissue test. Because wafers can affect later treatment choices, including trial eligibility, teams discuss the option with patients and families beforehand where possible, including the benefits, risks, costs and availability. If wafers are not used, standard treatment with radiotherapy and chemotherapy tablets after surgery remains the main approach for many patients.

Life after brain tumour surgery

Recovery after brain surgery varies widely. Some people return home within days, while others need longer hospital care and rehabilitation. Tiredness, headaches, changes in memory or mood, and difficulties with speech or movement can occur, depending on where the tumour was. Physiotherapists, occupational therapists, speech therapists and psychologists can help. Families often need support too, as caring for someone after brain surgery can be emotionally and practically demanding.

Seizures and daily safety

Seizures can happen after brain surgery. Follow advice about seizure medicines, avoid driving until allowed, and make sure family know what to do if a seizure occurs.

Questions for your neurosurgeon

Ask whether wafers are recommended for you, why, what the alternatives are, and how they would affect later treatment.

What to do next

Ask your neurosurgeon whether wafers are an option for your tumour, what the evidence, risks and costs are, whether they affect trial eligibility, and what recovery and further treatment will involve.